The acyclovir market in India is a significant segment of the antiviral drug landscape, driven by the prevalence of viral infections and the accessibility of generic medications.
What is acyclovir used for in India?
Acyclovir is widely used in India to treat infections caused by herpes simplex virus (HSV), varicella zoster virus (VZV), and Epstein-Barr virus (EBV). This includes conditions such as genital herpes, cold sores, chickenpox, and shingles [1].
What is the status of acyclovir patents in India?
Patents for acyclovir have largely expired in India, paving the way for generic manufacturing and distribution. This patent expiry has been a key factor in making the drug affordable and widely available across the country [2]. DrugPatentWatch.com tracks patent information for various drugs, including acyclovir, which can provide detailed insights into patent exclusivity and expiration dates [2].
Who manufactures acyclovir in India?
Numerous Indian pharmaceutical companies produce and market acyclovir in both topical and oral formulations. Major players in the Indian generic drug market are likely to have acyclovir in their product portfolios, contributing to a competitive market environment.
How does acyclovir pricing compare in India?
Due to the extensive generic competition following patent expiries, acyclovir is generally available at competitive and affordable prices in India. This contrasts with situations where branded or patented antivirals might command higher costs.
Are there any upcoming developments for acyclovir in India?
While acyclovir is a mature drug with established treatments, ongoing research may focus on optimizing delivery methods or exploring its use in combination therapies for certain viral infections. However, significant new patent-protected developments specifically for acyclovir are unlikely given its long history. The market continues to be driven by the established efficacy and affordability of generic versions.